fda compounding semaglutide news november 2025 Compounded weight loss injections — knock-offs are not the same – Partnership for Safe Medicines September 2, 2025: U.S. compounding

Survodutides published data points in a similar direction glycemic marker improvement and weight-related changes consistent with the broader dual-agonist class but the sample sizes and trial duration behind these findings are still catching up to the tirzepatide dataset

Compounding pharmacies are creating effective, legitimate medications, but those medications need more careful handling than their brand-name counterparts

Resistance training is your insurance policy against regain

Not available to Medicare or Medicaid beneficiaries

Each retatrutide vial is independently verified to 99% HPLC purity with a Certificate of Analysis available on request